BridgeMD
New treatment option for Solid Tumors
Official title A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
ClinicalTrials.gov ID: NCT07415031
What this study is testing
What is Adagrasib?
Adagrasib is an investigational medicine, being studied as a potential treatment for solid tumors.
Also referred to as BMS-986503.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other advanced solid tumors.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant is eligible to receive continued study treatment as per the parent study, and/or investigator assessed clinical benefit.
- Individuals with assigned female sex at birth (AFSB) must have documented proof that they are not of childbearing potential. IOCBP participants who...
You likely can't join if
- Participant is not eligible for study treatment per the parent study eligibility criteria.
- Participants who have completed treatment with the study drugs, progressed on prior study treatment, or discontinued study treatment due to toxicity...
- Participants not receiving clinical benefit from parent study drug as assessed by the investigator. Other protocol defined inclusion/exclusion...
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Bellflower, California, United States
- Long Beach, California, United States
- Newark, Delaware, United States
- St. Petersburg, Florida, United States
- Wichita, Kansas, United States
- Boston, Massachusetts, United States
- Rochester, Minnesota, United States
- Saint Paul, Minnesota, United States
- Omaha, Nebraska, United States
- Eugene, Oregon, United States
- Germantown, Tennessee, United States
- Bedford, Texas, United States
- Dallas, Texas, United States
- Grapevine, Texas, United States
- Bellingham, Washington, United States
- St Leonards, New South Wales, Australia
- Ghent, Belgium
- Vancouver, British Columbia, Canada
- Beijing, Beijing Municipality, China
+ 72 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Bellflower, California, United States; Long Beach, California, United States; Newark, Delaware, United States; St. Petersburg, Florida, United States; Wichita, Kansas, United States and 86 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.